Articles Referencing LLY

Zacks.com

Amgen to Set Up JV in China - Analyst Blog

Amgen ( AMGN ) recently announced its intention to set up a joint venture (JV) in China with Zhejiang Beta Pharma Co., Ltd.  The JV will focus on the commercialization of Amgen's... Read >>

Zacks.com

Lilly Scraps Oncology Candidate - Analyst Blog

Eli Lilly and Company ( LLY ) recently announced a pipeline setback with its oncology candidate, enzastaurin, failing in a phase III study. Eli Lilly was evaluating enzastaurin as a... Read >>

NASDAQ.com News

Eli Lilly and Company (LLY) Ex-Dividend Date Scheduled for May 14, 2013

Eli Lilly and Company ( LLY ) will begin trading ex-dividend on May 14, 2013. A cash dividend payment of $0.49 per share is scheduled to be paid on June 10, 2013. Shareholders who purchased LLY... Read >>

Minyanville

For Farmers, Rise in Suicide Rate Is Old News

The recent news from the Centers for Disease Control and Prevention that more Americans now die of suicide than in car accidents made headlines . Though reasons for suicide are extremely... Read >>

Zacks.com

Earnings Preview: AmerisourceBergen - Analyst Blog

AmerisourceBergen ( ABC ) is set to report second quarter 2013 results on Apr 25, 2013. Last quarter, the company reported in-line results for the first quarter. Let's see how things are... Read >>

Zacks.com

Lilly Earnings Better Than Expected - Analyst Blog

Eli Lilly & Company ( LLY ) reported first quarter 2013 adjusted earnings per share of $1.14, well above the Zacks Consensus Estimate of $1.05 and 24% above the year-ago earnings of... Read >>

Zacks.com

Will Eli Lilly Beat Earnings in 1Q? - Analyst Blog

We expect Eli Lilly and Company ( LLY ) to beat earnings expectations when it reports first-quarter 2013 results before the opening bell on Apr 24, 2013. Why a Likely Positive Surprise? ... Read >>

NASDAQ.com News

Pre-Market Earnings Report for April 24, 2013 : PG, BA, LLY, F, EMC, SO, ERIC, PX, TMO, GD, HES, NVS

The following companies are expected to report earnings prior to market open on 04/24/2013. Visit our Earnings Calendar for a full list of expected earnings releases. Procter & Gamble... Read >>

Zacks.com

Will Amgen Beat Earnings? - Analyst Blog

We expect Amgen Inc. ( AMGN ) to beat earnings expectations when it reports first-quarter 2013 results after the closing bell on Apr 23, 2013. Why a Likely Positive Surprise? Our... Read >>

Zacks.com

Eli Lilly in Alzheimer's Deal - Analyst Blog

Eli Lilly and Company ( LLY ) recently announced the acquisition of a couple of investigational positron emission tomography (PET) tracers from Siemens Medical Solutions USA, Inc. The... Read >>

Zacks.com

Bristol-Myers Likely to Report In Line Earnings - Analyst Blog

We expect Bristol-Myers Squibb Company ( BMY ) to report in line first-quarter 2013 results before the opening bell on Apr 25. Factors to Consider this Quarter The genericization of... Read >>

Zacks.com

Forest Labs Likely to Miss 4Q Earnings - Analyst Blog

We expect Forest Laboratories Inc. ( FRX ) to miss earnings expectations when it reports fourth-quarter fiscal 2013 results on Apr 23, before the opening bell. Forest Labs' fiscal year ends... Read >>

Zacks.com

Biogen: Will it Miss Earnings Again? - Analyst Blog

We expect Biogen Idec, Inc. ( BIIB ) to report lower-than-expected earnings when it releases its first-quarter 2013 results before the opening bell on Apr 25. We note that Biogen had missed... Read >>

Zacks.com

Pipeline Progress at Alkermes - Analyst Blog

Alkermes ( ALKS ) recently announced encouraging top-line data from a phase II study (n=142) on ALKS 5461. The study evaluated the safety and efficacy of ALKS 5461 across two doses for the... Read >>

Zacks.com

Positive Data on Lilly Diabetes Candidate - Analyst Blog

Eli Lilly and Company ( LLY ) recently announced top-line data on its type II diabetes candidate, dulaglutide. The company said that dulaglutide met its primary endpoint in two phase III... Read >>

Displaying 1-15 of 182
<< first < previous 1 2 3 4 5 10 12 next > last >>